Clinical Trial Update: The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of neramexane in moderate-to-severe Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Neramexane (neramexane)

Snippet

Sponsor: Forest Laboratories | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED